Protalix BioTherapeutics
PLX
$1.14
Share price
-2.56%
Change (1 day)
-51.69%
Change (1 year)
Categories
Market capitalization of Protalix BioTherapeutics (PLX)
Market cap: $83.58 Million
As of May 2024 Protalix BioTherapeutics has a market cap of $83.58 Million. This makes Protalix BioTherapeutics the world's 7529th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Protalix BioTherapeutics from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $83.58 M | -35.64% |
| 2023 | $0.12 B | 87.08% |
| 2022 | $69.41 M | 83.2% |
| 2021 | $37.88 M | -68.69% |
| 2020 | $0.12 B | 148.64% |
| 2019 | $48.66 M | 5.47% |
| 2018 | $46.14 M | -50.05% |
| 2017 | $92.38 M | 67.73% |
| 2016 | $55.08 M | -45.89% |
| 2015 | $0.10 B | -40.9% |
| 2014 | $0.17 B | -52.64% |
| 2013 | $0.36 B | -25.05% |
| 2012 | $0.48 B | 14.95% |
| 2011 | $0.42 B | -47.68% |
| 2010 | $0.80 B | 50.76% |
| 2009 | $0.53 B | 283.05% |
| 2008 | $0.13 B | -45.77% |
| 2007 | $0.25 B | -75.03% |
| 2006 | $1.03 B | 4063.51% |
| 2005 | $24.78 M | 4150% |
| 2004 | $0.58 M | -50% |
| 2003 | $1.16 M | 263.64% |
| 2002 | $0.32 M | -52.17% |
| 2001 | $0.67 M |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Protalix BioTherapeutics was reported to be:
$83.58 Million
$83.58 Million
$83.94 Million
$83.58 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $162.29 B | 194,073.79% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $14.31 B | 17,032.78% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $2.83 B | 3,291.50% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $18.89 B | 22,502.23% | 🇮🇱 Israel |